Ricoh Biosciences, formerly Elixirgen Scientific, is a biotechnology company using proprietary human iPSC differentiation technology to accelerate drug discovery, disease modeling, and cell therapy development. It provides high-quality, scalable cellular platforms and assays to support research and therapeutic innovation.